Product NDC: | 16477-136 |
Proprietary Name: | Donatuss |
Non Proprietary Name: | Dihydrocodeine Bitartrate, Phenylephrine Hydrochloride, Guaifenesin |
Active Ingredient(s): | 7.5; 50; 7.5 mg/5mL; mg/5mL; mg/5mL & nbsp; Dihydrocodeine Bitartrate, Phenylephrine Hydrochloride, Guaifenesin |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16477-136 |
Labeler Name: | Laser Pharmaceuticals LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED OTHER |
Start Marketing Date: | 20091007 |
Package NDC: | 16477-136-16 |
Package Description: | 473 mL in 1 BOTTLE (16477-136-16) |
NDC Code | 16477-136-16 |
Proprietary Name | Donatuss |
Package Description | 473 mL in 1 BOTTLE (16477-136-16) |
Product NDC | 16477-136 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dihydrocodeine Bitartrate, Phenylephrine Hydrochloride, Guaifenesin |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20091007 |
Marketing Category Name | UNAPPROVED OTHER |
Labeler Name | Laser Pharmaceuticals LLC |
Substance Name | DIHYDROCODEINE BITARTRATE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 7.5; 50; 7.5 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |